Results The frequencies of the C allele and GC genotype at NOS2A promoter -969G→C were significantly higher in portal hypertension group (16.9%,33.8%) than in control group(8.8%,17.6%)( P <0.05),and positive correlation ( r =0.18) and association (OR=2.42) were noted.
Results The mean levels of plasma endotoxin and NO 2 -/NO 3 - (0 249±0 112 Eu/ml and 55 9±26 2 μmol/L) in portal hypertensive patients were significantly higher than those in the controls,and the highest values were observed in the portal venous blood.
The mean portal venous pressure of the portal hypertensive patients was 35 5±4 4 cm H 2O and was positively correlated with the levels of NO 2 -/NO 3 -( n =25, r =0 55, P <0 01). Positive correlation existed between them during the postoperative period ( r =0 57, P <0 05).
Methods: From August 1993 through August 1998, 200 patients with protal hypertension were treated with TIPSS or TIPSS plus modified Sugiura operation. Results: Except for 10 cases with portal occlusion and 5 cases with hepatocellular carcinoma, the tech-nical successful rate was 94.59%.
We recognized and honoured the important contributions of these Chinese pioneers in portal hypertension, recurrent pyogenic cholangitis, hepatocellular carcinoma and liver transplantation.
Splenic autotransplantation and oesophageal transection anastomosis in patients with portal hypertension (26 years clinical obse
The surgical treatment methods for cirrhosis patients complicated with portal hypertension are complicated.
From 1979 to 2005, 274 cirrhosis patients with portal hypertension who underwent the new treatment strategy were followed up to observe different clinical indexes, which were then compared with those of the traditional surgery treatment.
Splenic auto transplantation and esophageal transection anastomosis are a safe, effective, and reasonable treatment strategy for portal hypertension with varicial bleeding.
The uses include variceal hemorrhage and ascites as well as miscellaneous indications such as Budd-Chiari syndrome, veno-occulsive disease, bleeding ectopic and rectal varices, hepatic hydrothorax, and portal hypertensive gastropathy.
Other more novel indications include bleeding portal hypertensive gastropathy or ectopic varices, Budd-Chiari syndrome, veno-occlusive disease, hepatorenal syndrome, hepatopulmonary syndrome, hepatocellular carcinoma, and polycystic liver disease.
Portal hypertensive gastropathy and gastric antral vascular ectasia
Portal hypertensive gastropathy (PHG) causes both acute and chronic blood loss from the gastrointestinal tract in patients with portal hypertension.
The classification of cirrhotic liver disease by Child and Turcotte was initially utilized to predict mortality in patients undergoing surgically placed shunts for portal hypertensive bleeding.